Syngenta SFr500m offer and listing set for November 10

  • 06 Oct 2000
Credit Suisse First Boston and UBS Warburg will launch the SFr500m (£313m) secondary offer for Novartis and AstraZeneca spinoff Syngenta at the end of October. The deal will offer both shares, to be listed in Zurich, London, Stockholm and American Depository Shares (ADSs) to be listed in New ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 325,692.23 1268 8.08%
2 JPMorgan 318,171.08 1387 7.90%
3 Bank of America Merrill Lynch 293,301.12 1008 7.28%
4 Barclays 245,918.13 920 6.10%
5 Goldman Sachs 217,162.09 730 5.39%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 45,688.28 179 7.05%
2 JPMorgan 43,572.44 88 6.72%
3 UniCredit 35,452.34 152 5.47%
4 Credit Agricole CIB 33,170.05 159 5.12%
5 SG Corporate & Investment Banking 32,244.80 125 4.97%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13,643.79 60 8.96%
2 Goldman Sachs 13,204.47 65 8.68%
3 Citi 9,716.40 55 6.38%
4 Morgan Stanley 8,471.86 53 5.57%
5 UBS 8,136.41 33 5.35%